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PRESCRIPTION 
Monitoring Program (PMP)
Checking the PMP:   
An important step to  
improving opioid  
prescribing practices 
What is a PMP? 
The PMP is a health care tool for practitioners to assist in  
identifying potential diversion, misuse or abuse of controlled 
substances by their patients while facilitating the most  
appropriate and effective medical use of those substances.  
PMPs improve patient safety by allowing clinicians to: 
 Identify patients who are obtaining opioids from  
 multiple providers.
	Calculate the total amount of opioids prescribed per day  
 (in MME/day).
 Identify patients who are being prescribed other  
 substances that may increase risk of overdose –  
 such as benzodiazepines.
Multiple  
Providers 
Counsel your patient and coordinate  
care with their other prescribers to  
improve safety and discuss the need  
to obtain opioids from a single provider. 
Check the PMP regularly and consider 
tapering or discontinuation of opioids  
or use of other non-pharmacologic 
methods.
Drug Interactions 
When indicated, avoid prescribing  
opioids and benzodiazepines  
concurrently. Communicate with other 
prescribers to prioritize patient goals  
and weigh risks of concurrent opioid  
and benzodiazepine use.
Dosage 
Consider explaining to your patient 
what Morphine Milligram Equivalents 
(MME) are and risks associated with 
exceeding 50MMEs per day. Discuss 
the possibility of tapering/reducing 
opioids as well as prescribing  
naloxone for patients taking 50MME/
day or more.
When should I  
check the PMP? 
The CDC recommends checking:
■ Prior to prescribing any opioid or controlled substance. 
■ Every three months. 
■ Utilize support staff as your delegates or agents for  
 checking the PMP when a patient arrives to the clinic  
 or hospital to save time.
Check every 3 months!
What should I consider  
when prescribing controlled substances?
 Iowa’s
Patients should not be dismissed from care based on PMP  
information. Use the opportunity to provide potentially  
life-saving information and interventions.
	 Conﬁrm	that	the	information	in	the	PMP	is	correct.	
 Check for potential data entry errors, use of a nickname or maiden  
 name, or possible identity theft to obtain prescriptions. 
 Assess for possible misuse or abuse. 
 Use a screening process such as SBIRT to assess for possible  
 misuse or abuse with a valid tool: i.e., the Drug Abuse Screening  
 Test (DAST). Assess risk with the Opioid Risk Tool (ORT), then  
 partner with a treatment provider for referral when needed. Visit  
 the www.yourlifeiowa.org website.
 Discuss any areas of concern with your patient and  
 emphasize your interest in their safety. Consider entering  
 the patient into a formal pain contract, if not already established.
How can I register  
and use the Iowa PMP? 
 
Visit this link:  
https://pmp.iowa.gov/ 
IAPMPWebCenter/Login.aspx
Created November 2017.
PMP Facts
■ You may allow up to six delegates   
 or agents (non-prescribing employees  
 in your practice whom you designate  
 to access the PMP) to register under  
 your supervision.
■ Iowa’s PMP provides information from  
 all states that utilize a PMP and have  
 an agreement with the state of Iowa to  
 share information.
■ Only licensed pharmacies are required  
 to report data to the Iowa PMP.
■ With recent legislative authority, the  
 Iowa PMP can connect with your  
 clinic/hospital EHR/EMR software.
 
Iowa PMP: Doses Dispensed
What should I do if I find information  
about a patient in the PMP that concerns me? 
IDPH
Iowa Department
of Public Health
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2. 
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The U.S. makes up < 5% of the world’s population, but 
consumes about 75% of its prescription drugs,
including 81% of its oxycodone and 99% of its hydrocodone.
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